These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28228147)

  • 1. Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.
    Lee HB; Piao DC; Lee JY; Choi JY; Bok JD; Cho CS; Kang SK; Choi YJ
    Microb Cell Fact; 2017 Feb; 16(1):33. PubMed ID: 28228147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
    Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide.
    Blanco E; Guerra B; de la Torre BG; Defaus S; Dekker A; Andreu D; Sobrino F
    Antiviral Res; 2016 May; 129():74-80. PubMed ID: 26956030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.
    Borrego B; Argilaguet JM; Pérez-Martín E; Dominguez J; Pérez-Filgueira M; Escribano JM; Sobrino F; Rodriguez F
    Antiviral Res; 2011 Nov; 92(2):359-63. PubMed ID: 21820470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle.
    Fang M; Wang H; Tang T; Zhao P; Du J; Guo S; Wei H; Xu H; Wan M; Wei X; Yu Y; Wang L
    Int Immunopharmacol; 2015 Oct; 28(2):960-6. PubMed ID: 26365702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
    Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
    Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.
    Gülçe İz S; Döşkaya M; Borrego B; Rodriguez F; Gürüz Y; Gürhan ID
    Vet Res Commun; 2013 Sep; 37(3):187-96. PubMed ID: 23483312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.
    Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.
    Cao Y; Lu Z; Li P; Sun P; Fu Y; Bai X; Bao H; Chen Y; Li D; Liu Z
    J Virol Methods; 2012 Oct; 185(1):124-8. PubMed ID: 22766183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
    Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
    Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.